Healthcare
Live Price
Offline$179.98
-0.23% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
AmerisourceBergen Corporation (ABC) is a Healthcare stock with a market cap of $36.15B and listed on NYSE. The stock last traded around $179.98. Baseline metrics include revenue growth of +9.3%, EPS growth of +5.5%, a dividend yield of 0.8%. What stands out right now is revenue +9.3%, EPS +5.5%, free cash flow +7.0% with operating margin 1.2% and ROIC 13.8%. The dividend is present but secondary, with a yield around 0.8%. Valuation already assumes a fairly strong business story at P/E 36.3 and price/sales 0.2. Stock Foundry combines ABC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ABC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ABC Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ABC and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$214.0B
-10.3% YoY
FY Net Income
$1.5B
-9.4% YoY
Free Cash Flow
$2.2B
+1.0% YoY
Revenue Growth
+9.3%
EPS Growth
+5.5%
Gross Margin
3.3%
Net Margin
0.5%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 321.3B | 294.0B | 262.2B | 238.6B | 214.0B |
| Gross Profit | 11.5B | 9.9B | 9.0B | 8.3B | 6.9B |
| Operating Income | 2.6B | 2.2B | 2.3B | 2.4B | 2.4B |
| EBITDA | 3.6B | 2.2B | 3.4B | 3.5B | 3.4B |
| Net Income | 1.6B | 1.5B | 1.7B | 1.7B | 1.5B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.4B | 3.1B | 2.6B | 3.4B | 2.5B |
| Total Assets | 76.6B | 67.1B | 62.6B | 56.6B | 57.3B |
| Total Liabilities | 75.1B | 66.5B | 62.0B | 56.5B | 56.8B |
| Shareholder Equity | 1.5B | 646M | 522M | -290M | 223M |
| Total Debt | 7.7B | 4.4B | 4.8B | 5.7B | 6.7B |
| Net Debt | 3.3B | 1.3B | 2.2B | 2.3B | 4.1B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2.7B
-1.4% YoY
Capital Expenditures
438M
+11.7% YoY
Free Cash Flow
2.2B
+1.0% YoY
Key ratios
Gross Margin
3.3%
Operating Margin
1.2%
Net Margin
0.5%
ROE
101.4%
Debt / Equity
4.15x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.